These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 32426957)

  • 1. Should coronavirus disease 2019 concern rheumatologists?
    Kucharz EJ
    Pol Arch Intern Med; 2020 Aug; 130(7-8):655-661. PubMed ID: 32426957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rheumatologists' practice during the Coronavirus disease 2019 (COVID-19) pandemic: a survey in Egypt.
    Gheita TA; Salem MN; Eesa NN; Khalil NM; Gamal NM; Noor RA; Moshrif AH; Shereef RE; Ismail F; Noshy N; Fawzy RM; Elshebini E; Khalifa I; Saadany HE; Tharwat S; El-Najjar A; Fattah YA; Sallam R; El-Bahnasawy AS; Gharbia O; Hassan E; ElShanawany A; Mohamed EF; Senara S; Ismail M; Nasef SI; Abdalla AM; Elessawi D; Fawzy SM; Alfadl EA; Khalifa A; Abaza NM;
    Rheumatol Int; 2020 Oct; 40(10):1599-1611. PubMed ID: 32710198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.
    Yazdany J; Kim AHJ
    Ann Intern Med; 2020 Jun; 172(11):754-755. PubMed ID: 32232419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 and what pediatric rheumatologists should know: a review from a highly affected country.
    Licciardi F; Giani T; Baldini L; Favalli EG; Caporali R; Cimaz R
    Pediatr Rheumatol Online J; 2020 Apr; 18(1):35. PubMed ID: 32321540
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rheumatologists' perspective on coronavirus disease 19 (COVID-19) and potential therapeutic targets.
    Misra DP; Agarwal V; Gasparyan AY; Zimba O
    Clin Rheumatol; 2020 Jul; 39(7):2055-2062. PubMed ID: 32277367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19: an unexpected indication for anti-rheumatic therapies?
    Lucchino B; Di Franco M; Conti F
    Rheumatology (Oxford); 2020 Jun; 59(6):1200-1203. PubMed ID: 32374874
    [No Abstract]   [Full Text] [Related]  

  • 7. What is the role of rheumatologists in the era of COVID-19?
    Marotto D; Sarzi-Puttini P
    Autoimmun Rev; 2020 Jun; 19(6):102539. PubMed ID: 32251716
    [No Abstract]   [Full Text] [Related]  

  • 8. Managing rheumatic diseases during COVID-19.
    Ladani AP; Loganathan M; Danve A
    Clin Rheumatol; 2020 Nov; 39(11):3245-3254. PubMed ID: 32895747
    [TBL] [Abstract][Full Text] [Related]  

  • 9. How to manage rheumatic patients during the coronavirus pandemic.
    Parisi S; Ditto MC; Finucci A; Fusaro E
    Panminerva Med; 2020 Sep; 62(3):176-177. PubMed ID: 32343511
    [No Abstract]   [Full Text] [Related]  

  • 10. Hydroxychloroquine: A Potential Ethical Dilemma for Rheumatologists during the COVID-19 Pandemic.
    Scuccimarri R; Sutton E; Fitzcharles MA
    J Rheumatol; 2020 Jun; 47(6):783-786. PubMed ID: 32241801
    [No Abstract]   [Full Text] [Related]  

  • 11. Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine.
    Sahraei Z; Shabani M; Shokouhi S; Saffaei A
    Int J Antimicrob Agents; 2020 Apr; 55(4):105945. PubMed ID: 32194152
    [No Abstract]   [Full Text] [Related]  

  • 12. Hydroxychloroquine and Chloroquine in COVID-19: A Survey of Prescription Patterns Among Rheumatologists.
    Mehta B; Moezinia CJ; Jannat-Khah D; Gibofsky A; Tornberg H; Pearce-Fisher D; Goodman SM; Salmon JE; Ibrahim S
    J Clin Rheumatol; 2020 Sep; 26(6):224-228. PubMed ID: 32694358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Coronavirus disease 2019 (COVID-19) and anti-rheumatic drugs.
    Georgiev T
    Rheumatol Int; 2020 May; 40(5):825-826. PubMed ID: 32232552
    [No Abstract]   [Full Text] [Related]  

  • 14. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
    Piszczatoski CR; Powell J
    Ann Pharmacother; 2020 Aug; 54(8):827-831. PubMed ID: 32389025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chiral switches of chloroquine and hydroxychloroquine: potential drugs to treat COVID-19.
    D'Acquarica I; Agranat I
    Drug Discov Today; 2020 Jul; 25(7):1121-1123. PubMed ID: 32371138
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of chloroquine or hydroxychloroquine in treatment of COVID-19: is it ethical?
    Allam MF; Andraous F
    Cent Eur J Public Health; 2020 Sep; 28(3):246-247. PubMed ID: 32997483
    [No Abstract]   [Full Text] [Related]  

  • 17. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review.
    Pereira BB
    J Toxicol Environ Health B Crit Rev; 2020 May; 23(4):177-181. PubMed ID: 32281481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chloroquine and hydroxychloroquine for the prevention and therapy of coronavirus disease 2019: new hopes and old cardiovascular concerns.
    Jankowska EA; Sierpiński R; Tkaczyszyn M; Drozd M; Szachniewicz J; Duda-Sikuła M; Knysz B; Simon K; Szenborn L; Ponikowski P
    Kardiol Pol; 2020 Aug; 78(7-8):811-817. PubMed ID: 32687267
    [No Abstract]   [Full Text] [Related]  

  • 19. Recommendations for coronavirus infection in rheumatic diseases treated with biologic therapy.
    Ceribelli A; Motta F; De Santis M; Ansari AA; Ridgway WM; Gershwin ME; Selmi C
    J Autoimmun; 2020 May; 109():102442. PubMed ID: 32253068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brief Review of Chloroquine and Hydroxychloroquine Toxicity and Management.
    Lebin JA; LeSaint KT
    West J Emerg Med; 2020 Jun; 21(4):760-763. PubMed ID: 32726238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.